Cite
HARVARD Citation
Harden, P. et al. (2021). Feasibility, long‐term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients. American journal of transplantation. 21 (4), pp. 1603-1611. [Online].